Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients
NCT ID: NCT01718821
Last Updated: 2014-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2012-09-30
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of the Digital Multimedia Health Education in Improving Cancer Pain, Analgesic Adherence, and Pain Control Satisfaction With Cancer Patient
NCT06791213
Intelligent Pain Management System for Assessing Pain in Cancer Patients
NCT02765269
Digestive Tract Cancer and CIPN
NCT06331962
Investigation of Pain and Symptom Burden in Patients With Newly Diagnosed Head and Neck Cancer
NCT00655005
Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic
NCT03043378
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Advanced upper GI cancer patients
Upper GI cancers include: esophageal cancer, gastric cancer, ampulla vater cancer, pancreatic cancer and cholangiocarcinoma.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* could report pain intensities and answer questionnaires by him/herself
Exclusion Criteria
* could not report pain intensities and answer questionnaires by him/herself
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cheng Kung University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hsu-chih Chien
Doctoral student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yea-huei Kao Yang
Role: PRINCIPAL_INVESTIGATOR
Institute of Clinical Pharmacy and Pharmaceutical Science, National Cheng Kung University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cheng Kung University Hospital
Tainan City, Tainan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A-ER-101-134
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.